NCT06677697View on ClinicalTrials.gov

Comparative Study of Bupivacaine and Ropivacaine in Lumber Epidural Lower Limb Bypass Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 1, 2021

Primary Completion Date

October 30, 2022

Study Completion Date

November 1, 2022

Conditions
Lower Limb Injuries
Interventions
DRUG

Ropivacaine 0,5%

Group B 30 patients recive 0.5% ropivacine

Trial Locations (1)

Unknown

Ibrahim Cardiac Hospital and Research Institute, Dhaka

All Listed Sponsors
collaborator

Bangladesh Institute of Research and Rehabilitation in Diabetes, Endocrine and Metabolic Disorders

OTHER

lead

ibrahim cardiac hospital and research institute

OTHER

NCT06677697 - Comparative Study of Bupivacaine and Ropivacaine in Lumber Epidural Lower Limb Bypass Surgery | Biotech Hunter | Biotech Hunter